Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Larissa Cristina Barbosa Flores
Observed names:
Flores, Larissa Cristina Barbosa,
L. Flores
Institution:
Universidade Federal do Rio Grande do Sul
Observed institutions:
Universidade Federal do Rio Grande do Sul,
Massachusetts General Hospital,
Hospital de Clínicas de Porto Alegre,
Institut Català d'Oncologia,
PharmaMar (Spain),
Dana-Farber Cancer Institute
show all 6
ORCID:
0009-0003-3345-8712
Observed ORCID:
0009-0003-3345-8712
OpenAlex ID:
A5112092767
Phase II study of three hour, weekly infusion of trabectedin (ET-743) in men with metastatic, androgen-independent prostate carcinoma (AIPC)
2005
·
M. D. Michaelson
, T. Gilligan
, et al.
·
Journal of Clinical Oncology
·
15
TBCRC 003: Phase II trial of trastuzumab (T) and lapatinib (L) in patients (pts) with HER2+ metastatic breast cancer (MBC).
2011
·
N. U. Lin
, I. A. Mayer
, et al.
·
Journal of Clinical Oncology
·
12
The role of EGFR amplification in trastuzumab resistance: A correlative analysis of TBCRC003.
2011
·
I. E. Krop
, L. Flores
, et al.
·
Journal of Clinical Oncology
·
7
Newborn Intravenous Injection of Liposomal CRISPR/Cas9 Complex Has No Incidence of Off-Targets or Tumors in Mice
2025
·
Vinícius Monteagudo
, Larissa Cristina Barbosa Flores
, et al.
·
Pharmaceutics
·
2
PDF
Phase II trial of preoperative vinorelbine/trastuzumab (VH) or docetaxel/carboplatin/trastuzumab (TCH) in HER2-positive breast cancer with analysis of resistance mechanisms.
2010
·
I. E. Krop
, L. Flores
, et al.
·
Journal of Clinical Oncology
·
2
Comparison of the Cellsearch Profile Kit (CPK) with the Standard Cellsearch Epithelial Kit (CEK) Demonstrates the CPK Produces Higher Circulating Tumor Cell (CTC) Yields and Is Better Suited for Use in Obtaining CTC's for Molecular Characterization.
2009
·
L. Flores
, D. Kindelberger
, et al.
·
Cancer Research
·
1
550 Phase I and pharmacokinetic (PK) study of trabectedin (ET-743) administered as a 1-hour infusion weekly for 3 consecutive weeks every 4 weeks to patients with advanced cancer
2004
·
S.Q. Chu
, G. Schwartz
, et al.
·
European Journal of Cancer Supplements
·
1
Avaliação In Vitro de Nanoemulsões Espessadas com Poloxâmero 407 como Co-carreadoras de Crispr/Cas9 e Dexametasona para Edição Gênica da Mucopolissacaridose Tipo I
2026
·
Júlia de Azambuja Vaniel
, Letícia Jesus Hipólito De Souza
, et al.
·
Jornal de Assistência Farmacêutica e Farmacoeconomia
Phase I combination study of plitidepsin and carboplatin in advanced solid tumours
2007
·
A. Oaknin
, R. Plummer
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
11
Citation count:
41
H-index:
3
I10-index:
2
Year
Topic
Type